Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2015

European Healthtech startup funding raised during H2 2015.

In H2 2015, 136 European Healthtech companies closed 141 funding rounds and raised €1.3B in equity funding (excluding debt and grants), up 135.6% versus H2 2014. Debt rounds added €103M. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.3B
+135.6% vs H2 2014 · excl. debt & grants · +€103M debt
Funding rounds
141
+120.3% vs H2 2014
Companies
136
Top country
Switzerland
Rank among sectors
#2
12.8% of sector funding
Debt financing
€103M
7.4% of total
Top-10 round share
45.9%
of disclosed capital

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2015 — interactive chart.
Data table
FundingRounds
Jul€119M21
Aug€207M11
Sep€405M29
Oct€184M26
Nov€378M31
Dec€102M23

Top countries

by € raised
Healthtech — top countries by capital, H2 2015 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2015
Switzerland€307M
UK€289M
Israel€146M
France€131M
Germany€116M
Netherlands€107M
Spain€71M
Denmark€69M

Stage mix

by € raised
Healthtech — stage mix, H2 2015 — interactive chart.
Data table
Healthtech — stage mix, H2 2015
Series C€367M
Series A€252M
Growth/Late€228M
Series B€205M
Series D+€124M
Debt€103M
Early VC€58M
Seed€41M
Grant€17M
Other€1.0M

Exits & M&A

6 Acquisition

6 exits · €526M disclosed.

Biotie TherapiesAcquisitionSep 2015€330M
WiThingsAcquisitionDec 2015€170M
ClipFortAcquisitionDec 2015€26M

Top deals

largest disclosed rounds in H2 2015
CompanyStageDateAmount
CureVacSeries D+Nov 2015€100M
CeQurSeries CSep 2015€89M
BenevolentGrowth/LateAug 2015€80M
MerusSeries CAug 2015€73M
ADC TherapeuticsGrowth/LateSep 2015€71M
SymphogenDebtOct 2015€68M
ObsEvaSeries BNov 2015€54M
SanifitSeries CSep 2015€37M
DNAe LTDDebtNov 2015€35M
BimaSeries CJul 2015€34M
GenSight BiologicsSeries BJul 2015€32M
NightstaRxSeries BNov 2015€32M
Biom'UpSeries CSep 2015€31M
TherachonSeries ASep 2015€31M
PREP BiopharmSeries ANov 2015€29M